Skip to main content
. 2023 Jan 25;13:1388. doi: 10.1038/s41598-023-28351-3

Figure 2.

Figure 2

Comparison of histopathological characteristics between metabolic dysfunction-associated fatty liver disease with and without hepatitis B virus (HBV) infection. (A) Comparison of hepatic steatosis score segregated by HBV infection; (B) comparison of ballooning score segregated by HBV infection; (C) comparison of inflammation score segregated by HBV infection; (D) comparison of fibrosis stage segregated by HBV infection.